ABC4, Lisbon 2017: day two report
Day two of ABC-Lisbon featured a pioneer in metastatic breast cancer advocacy, Musa Mayer, who gave the ABC Award lecture. Mayer told the history of how the “silent voices” of women with advanced disease came [more]
resistance
Unlocking progress: why we need to change the culture of biobanking
Progress in understanding resistance and learning how to combine and sequence therapies most effectively is being stifled because specimens donated by patients, and related data, are being hoarded and not shared. Peter McIntyre reports. There [more]
Targeting the supply lines: metabolic approaches to killing cancer cells
Recent years have seen a revival of interest in the unique metabolism of cancer cells. This time the focus is on the potential it offers as a target, rather than any possible causal role [more]
Intratumoural drug metabolism and the disposition of anticancer agents: implications for clinical treatment
Pharmacokinetics within tumour cells play an important role in the development of resistance. A better understanding of the mechanisms involved is important for devising treatment strategies to extend tumour response. We know that cancer cells [more]
Biology in the bunker
Advances in imaging and molecular biology are opening up a wealth of new avenues for research and treatment in radiotherapy. But could progress be held back by a lack of public awareness of the potential [more]
Deconstructing evolution: can number crunchers find the answer to resistance?
Is there a logic, a pattern, a system behind the way cancer cells adapt to develop resistance to agents designed to kill them? Cancer research is calling on systems biologists to see if they can [more]